摘要 ： 在2025年医药领域实施的新标准中，科学仪器应用显著提升，色谱、质谱、光谱技术成核心手 段，推动药品、医疗与器械高质量监管。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 2 0 2 5年共有4 7 6份新医药标准实施，其中科学仪器的应用广度与深度达到新高度： 精密检测的支柱 ： 新标准显著强化了色谱、质谱与光谱技术的应用。例如，气相/液相色谱- 质谱联用法（GC-MS/LC-MS）已成为血液、尿液及生物检材中数百种毒物、药物成分鉴定的 核心手段；电感耦合等离子体质谱（ICP-MS）则被确立为检测生物检材中3 2种微量元素及医 用质谱仪性能评价的重要标准。 药典升级的引擎 ： 2 0 2 5年版《中国药典》通过修订质谱法、核磁共振波谱法等通则，极大促 进了国产仪器的创新。近红外光谱、原子荧光光谱等先进技术的引入，不仅提升了检测效率， 更通过数字化手段取代了传统剧毒试剂检测，践行了绿色监管理念。 前沿领域的导向 ： 在新实施的医疗器械标准中，人工智能影像设备、手术机器人及数字化X 射线探测器等高精尖仪器成为关注重点，推动了诊疗过 ...

在汇总的465份新标准中，色谱、质谱及光谱技术应用广泛，除此之外还有一些常用的分析方 法如滴定的方法也应用广泛。如果您想查阅更多的其他行业新实施标准，可以点击 阅 读 原 文 进行查询、查新。 摘要 ： 在2025年石油化工行业有465项新标准实施，在这些标准中涉及多种科学仪器检测方法，如色 谱、质谱、光谱、滴定等分析仪器技术 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 我们已整理2025年新实施标准的食品篇、环境篇汇总，深受广大行业用户的关注，接下来请 跟随我们一起梳理下石油化工行业2025年新实施的标准又有哪些？下面我们将一一揭晓。 2025年 石油化工行业 新实施标准如下： | 标准号 | 标准名称 | | --- | --- | | | 标准名称中包含"色谱/质谱/光谱仪器"的标准 | | GB/T | 烟花爆竹 特定化学物质检测方法 第12部分：苦味酸和苦味酸盐 | | 46122.12- | 含量的测定 高效液相色谱法 | | 2025 | | | GB/T | 烟花爆竹 特定化学物质检测方法 第2部分：六氯代苯含量的测 ...

Core Viewpoint - ST Tianrui is undergoing a potential change in control, with its major shareholder and actual controller Liu Zhaogui planning to transfer control of the company, which may lead to a change in the company's controlling shareholder and actual controller [1] Group 1: Control Change Plans - Liu Zhaogui is currently planning a change in the company's control, with no agreements signed yet, and discussions ongoing regarding specific transaction plans [1] - The stock of ST Tianrui will be suspended from trading starting December 1, 2025, for a period not exceeding two trading days [1] - In May 2023, Liu Zhaogui had previously planned to transfer control of the company, signing a share transfer agreement with Guangzhou Liduo Virtual Reality Technology Partnership [1][2] Group 2: Share Issuance and Ownership Changes - The company signed a share subscription agreement with Guangzhou Liduo Technology Partnership, planning to issue up to 148,650,000 shares, raising a total of no more than 624.33 million yuan [2] - If the share transfer and issuance are completed, Liduo Virtual will hold 24,825,137 shares (3.85% of total shares post-issuance), and Liduo Technology will hold 148,650,000 shares (23.08% of total shares post-issuance), resulting in a change of control [2] Group 3: Financial Performance and Regulatory Issues - ST Tianrui has faced financial difficulties, reporting losses for four consecutive years since 2021, with a cumulative loss of 353 million yuan [3] - In the first three quarters of this year, the company reported revenue of 434.9 million yuan, a year-on-year decline of 26.15%, and a net profit loss of 1.218 million yuan, which is an improvement compared to the previous year [3] - Prior to the termination of the control change plan, the company was under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [3]

Core Viewpoint - ST Tianrui is undergoing a potential change in control, as announced by its controlling shareholder and chairman Liu Zhaogui, with no agreements signed yet [1] Company Overview - ST Tianrui is a high-tech enterprise with independent intellectual property, owning nine wholly-owned subsidiaries and five controlling subsidiaries, specializing in the research, production, and sales of analytical testing instruments and software [2] Financial Performance - For the first three quarters of 2025, ST Tianrui reported a revenue of 435 million yuan, a year-on-year decrease of 26.15%, and a net profit attributable to shareholders of a loss of 1.22 million yuan [2] Stock Information - As of November 28, ST Tianrui's stock price was 4.64 yuan per share, with a total market capitalization of approximately 2.3 billion yuan [3]

Core Viewpoint - ST Tianrui (300165) is undergoing a potential change in control, as announced by its chairman Liu Zhaogui, with no agreements signed yet [2][4]. Company Overview - ST Tianrui is a high-tech enterprise with independent intellectual property rights, operating nine wholly-owned subsidiaries and five controlling subsidiaries, focusing on the research, production, and sales of analytical testing instruments [4]. Financial Performance - For the first three quarters of 2025, ST Tianrui reported a revenue of 435 million yuan, a year-on-year decrease of 26.15%, and a net loss attributable to shareholders of 1.22 million yuan [5][6]. - The company's revenue for the latest reporting period was approximately 140 million yuan, reflecting a decline of 33.03% compared to the same period last year [6]. - The net profit attributable to shareholders for the same period was approximately 8.37 million yuan, an increase of 3.95% year-on-year [6]. - The basic earnings per share for the latest reporting period was 0.0169 yuan, up 4.22% from the previous year [6].

Group 1: Financial Performance - In the first three quarters of 2025, the company achieved revenue of 2.05 billion yuan, a year-on-year decrease of 11.10% [1] - The net profit attributable to the parent company was -62 million yuan, indicating a shift from profit to loss compared to the previous year [1] - For Q3 2025, the company reported revenue of 755 million yuan, a year-on-year decrease of 15.61%, and a net profit of -12 million yuan, also reflecting a shift from profit to loss [1] Group 2: Profitability and Cost Management - The gross margin for the first three quarters of 2025 was 39.69%, down 4.68 percentage points year-on-year [1] - In Q3 2025, the gross margin was 38.58%, a decline of 5.68 percentage points year-on-year [1] - Operating efficiency remained stable, with a slight increase in period expenses; sales expenses were 422 million yuan, with a sales expense ratio of 20.59%, up 1.84 percentage points year-on-year [1] Group 3: Industry Position and Growth Potential - The company is a leading domestic high-end analytical instrument enterprise, continuously building a "4+X" multi-business layout [2] - Despite rapid growth in the domestic analytical instrument industry over the past decade, there remains a significant gap compared to leading companies in the US, Germany, and Japan [2] - The company has established a competitive barrier through a unique multiplier effect of "technology platform × application field" and is well-positioned to benefit from the urgent demand for domestic substitution in high-end products [2] Group 4: Future Earnings Forecast - The company is expected to achieve revenues of 3.66 billion, 4.26 billion, and 4.96 billion yuan for the years 2025 to 2027, with net profits of 57 million, 282 million, and 378 million yuan respectively [3] - Corresponding price-to-earnings ratios are projected to be 128.46, 26.09, and 19.49 times for the same period [3]

Core Viewpoint - The company plans to invest up to RMB 400 million in purchasing land use rights and constructing an innovation industrial base, focusing on chromatography and mass spectrometry production lines, in alignment with the national "dual carbon" strategy [2][3]. Group 1 - The company will acquire land use rights for the CP01-0801-0047 plot in the Huairou International Information Industry Base, designated for industrial use [2]. - The investment will support the development of carbon monitoring and measurement systems, as well as process instrumentation analysis, including various series of chromatography, spectroscopy, and mass spectrometry instruments [2]. - The project aims to enhance the company's technical research and development capabilities and innovation capacity, laying a solid foundation for sustainable future growth [3].

Core Viewpoint - The environmental analysis instrument industry is accelerating towards smart, high-precision, and domestically produced developments, driven by multi-technology integration that promotes real-time monitoring and dynamic control [4]. Group 1: Industry Development - The industry is in a critical development phase characterized by rapid technological iteration, deepening application scenarios, and is moving towards smart, high-precision, and domestically produced solutions [2]. - Traditional technologies such as chromatography, mass spectrometry, and spectroscopy are enhancing detection efficiency and adaptability through "hybridization" and "miniaturization" [2]. - The integration of sensor technology and AI algorithms is expanding the coverage of environmental analysis and transforming monitoring from "post-event detection" to "real-time warning and dynamic control" [2]. Group 2: Event Highlights - The 21st Beijing Conference on Analytical Testing (BCEIA 2025) was successfully held, featuring discussions on cutting-edge topics in environmental analysis and health, including the analysis of arsenic, new pollutants, and the application of AI in environmental big data [3]. - Notable scientists and researchers participated in the forum, focusing on key issues such as the rapid detection of perfluorinated compounds and the environmental behavior of micro-nano particles [3]. Group 3: Product Innovations - Companies showcased advanced products at the exhibition, including over 40 star products from 聚光科技, covering the complete analysis process from sample preparation to final detection [5]. - 雪迪龙 presented cutting-edge devices such as portable mass spectrometers and Fourier-transform infrared spectrometers, demonstrating innovations in high-end scientific instrument development [5]. - The environmental analysis field is evolving towards high precision, automation, intelligence, and portability, with products like the BRUKER MGA series achieving ppb to ppt level detection capabilities [39].

Group 1 - The company reported a revenue of 1.295 billion yuan for H1 2025, a year-on-year decrease of 8.23%, and a net profit attributable to shareholders of -51 million yuan, a decline of 210.86% [1] - Revenue breakdown shows that instrument, related software, and consumables generated 896 million yuan, down 7.39%; operational services, testing services, and consulting services brought in 213 million yuan, down 11.83%; environmental equipment and engineering earned 135 million yuan, down 2.30%; and other businesses contributed 50 million yuan, down 20.51% [1] - The company maintained stable operating expenses, with sales expenses at 285 million yuan (sales expense ratio of 22.01%, up 2.38 percentage points), management expenses at 134 million yuan (management expense ratio of 10.35%, up 0.71 percentage points), R&D expenses at 203 million yuan (R&D expense ratio of 15.68%, up 0.23 percentage points), and financial expenses at 61 million yuan, a decrease of 20 million yuan due to reduced interest expenses from loan repayments [1] Group 2 - The company is a leading domestic high-end analytical instrument enterprise, continuously building a "4+X" multi-business layout, creating unique competitive barriers through the "technology platform × application field" multiplier effect [2] - Despite rapid growth in the domestic analytical instrument industry over the past decade, there remains a significant gap compared to leading countries like the US, Germany, and Japan, with the top 20 global listed analytical instrument companies being monopolized by Europe, the US, and Japan [2] - The company has been recognized as a "national manufacturing single champion enterprise" and possesses leading domestic mass spectrometry, chromatography, and spectroscopy technologies and product platforms, positioning itself to benefit from the urgent demand for domestic alternatives [2] Group 3 - Revenue forecasts for the company from 2025 to 2027 are 3.987 billion yuan, 4.506 billion yuan, and 4.951 billion yuan, with net profits of 252 million yuan, 399 million yuan, and 460 million yuan, corresponding to PE ratios of 38.10, 24.07, and 20.86 times, maintaining a "buy" rating for the company [3]

Core Viewpoint - The article emphasizes the critical role of scientific instruments in the formulation and revision of 823 national standards across various sectors, including plastic chemicals, metal materials, information technology, equipment manufacturing, consumer product safety, energy environment, and medical devices [1][2]. Summary by Relevant Sections National Standards Overview - A total of 823 national standard drafts are open for public consultation, covering multiple fields such as plastic chemicals, metal materials, and medical devices [2]. - The extensive standardization work highlights the importance of scientific instruments as the "eyes" and "brains" of modern industry, relying on precise and reliable analytical testing methods and instrument technology advancements [2]. Instrumentation Technologies - Inductively Coupled Plasma (ICP) technology, including emission spectroscopy and mass spectrometry, is frequently mentioned as a key method for analyzing metal and alloy compositions, detecting environmental pollutants, and controlling impurities in high-purity materials [2]. - The family of ray technologies, including X-ray diffraction (XRD), X-ray fluorescence (XRF), and non-destructive testing (DR/CT), has expanded its application from traditional material phase analysis to residual stress measurement and online industrial inspection, showcasing its powerful penetration and information acquisition capabilities [2]. - Chromatography and spectroscopy (both molecular and atomic), along with mass spectrometry, form a core technology matrix for food safety, chemical identification, and material aging mechanism research [2]. Standardization and Methodology - The standards not only regulate product performance but also impose strict requirements on the methodologies, precision, and consistency of testing instruments, marking a shift from empirical judgment to a new phase of scientific evaluation driven by precision instruments and data [3]. - The article lists specific projects and their deadlines, such as the establishment of standards for biobased plastics' carbon and environmental footprints, and various standards related to industrial applications and asset management [3][5][6].